RORA and Autoimmunity: By targeting RORα, these synthetic modulators have demonstrated efficacy in inhibiting autoimmunity,24 and reducing blood glucose in diabetic mice.25 However, the exact influence of these small-molecule modulators targeting RORα in ameliorating circadian rhythm-related inflammatory diseases remains to be elucidated.